Mutiara Indah Sari

Dr. Mutiara Indah Sari

University of North Sumatra, Medan, Sumatera Utara, Indonesia
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
CHCeria Halim
Ceria Halim
AMAudrey Fabianisa Mirza
Audrey Fabianisa Mirza
MSMutiara Indah Sari
Mutiara Indah Sari
Background: An increasing number of scientific journals have proposed a connection between tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) and the severity of COVID-19. Vitamin D has been discussed as a potential therapy for COVID-19 due to its immunomodulatory effects. This meta-analysis aims to determine the relationship, if any, between TNF-α, IL-6, vitamin D, and COVID-19 severity and mortality. Methods: The design of the study is a systematic review and meta-analysis. A literature search is performed using PubMed, Cochrane, ProQuest, and Google Scholar. Results: TNF-α insignificantly increases the risk of COVID-19 severity (adjusted odds ratio (aOR) = 1.0304; 95% CI 0.8178–1.2983; p = 0.80) but significantly increases the risk of COVID-19 mortality (crude hazard ratio (HR) = 1.0640; 95% CI 1.0259–1.1036; p = 0.0009). IL-6 significantly increases the risk of COVID-19 severity (aOR = 1.0284; 95% CI 1.0130–1.0441; p = 0.0003) and mortality (aOR = 1.0076; 95% CI 1.0004–1.0148; p = 0.04; adjusted hazard ratio (aHR) = 1.0036; 95% CI 1.0010–1.0061; p = 0.006). There is a statistically insignificant difference of the mean vitamin D levels between patients with severe COVID-19 and non-severe COVID-19 (mean difference (MD) = −5.0232; 95% CI 11.6832–1.6368; p = 0.14). A vitamin D deficiency insignificantly increases the risk of mortality of COVID-19 patients (aOR = 1.3827; 95% CI 0.7103–2.6916; p = 0.34). Conclusion: IL-6 is an independent prognostic factor towards COVID-19 severity and mortality.

19 August 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
MSMutiara Indah Sari
Mutiara Indah Sari
SISyafruddin Ilyas
Syafruddin Ilyas
Sepsis is a series of life-threatening organ dysfunction caused by an impaired host response to infection. A large number of molecular studies of sepsis have revealed complex interactions between infectious agents and hosts that result in heterogeneous manifestations of sepsis. Sepsis can cause immunosuppression and increase the expression of checkpoint inhibitor molecules, including programmed death protein (PD-1) and programmed death ligand 1 (PD-L1), and thus PD-1 and PD-L1 are thought to be useful as diagnostic and prognostic tools for sepsis. PD-1 is an inhibitor of both adaptive and innate immune responses, and is expressed on activated T lymphocytes, natural killer (NK) cells, B lymphocytes, macrophages, dendritic cells (DCs), and monocytes, whereas PD-L1 is expressed on macrophages, some activated T and B cells, and mesenchymal stem cells as well as various non-hematopoietic cells. This systematic review aims to assess the PD-1 and PD-L1 protein expression levels and concentrations in septic and other infectious patients.

8 April 2018 in Open Access Macedonian Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
MSMutiara Indah Sari
Mutiara Indah Sari
NSNisrina Sari
Nisrina Sari
DDdewi masyithah Darlan
dewi masyithah Darlan
RPRaka Jati Prasetya
Raka Jati Prasetya
BACKGROUND: The incidence rate of diabetes mellitus has increased throughout the year. Various studies indicate that smoking may affect glucose metabolism and cause hyperglycemia in diabetes mellitus. This study aimed to compare the blood glucose and HbA1c level in diabetic smoking patients and non-smoking diabetic patients.METHODS: This study used the cross-sectional approach. The study population consisted of 30 diabetic smoking patients and 30 non-smoking diabetic patients. The diabetes history and the smoking status of the study population obtained by questionnaire-based interview, the blood glucose and HbA1c level were measured by hexokinase and immunoturbidimetry method using cobas 6000 analyser module c501 (Roche Diagnostics, Switzerland).RESULTS: The result in this study showed the fasting blood glucose, postprandial blood glucose, and HbA1c were higher by 23.64 mg/dl (p = 0.325), 58.00 mg/dl (p = 0.016), 0.39% (p = 0.412) in smoking diabetic patients compared to non-smoking diabetic patients. After statistical analysis, there was a significant difference (p < 0.05) of postprandial glucose level between smokers group and non-smokers group, but the non-significant difference of fasting blood glucose and HbA1cCONCLUSIONS: This study concluded that there was a significant difference in postprandial glucose level between smokers group and non-smokers group but the non-significant difference of fasting blood glucose and HbA1c.

23 March 2018 in IOP Conference Series: Earth and Environmental Science
Verified
Conference Paper
Open access
PDF file
DDdewi masyithah Darlan
dewi masyithah Darlan
FAF R Ananda
F R Ananda
MSMutiara Indah Sari
Mutiara Indah Sari
NAN K Arrasyid
N K Arrasyid
DSD I Sari
D I Sari

10 March 2019 in Open Access Macedonian Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
MSMutiara Indah Sari
Mutiara Indah Sari
ZTZaimah Z. Tala
Zaimah Z. Tala
DWDian Dwi Wahyuni
Dian Dwi Wahyuni
BACKGROUND: Hyperglycemia condition in diabetes mellitus (DM) influences proinflammatory cytokine levels and disrupts antioxidant balances. Glycated Hemoglobin is used as a biomarker of glycemic control in DM. AIM: This study aimed to analyse the association between glycated Hemoglobin with the levels of serum proinflammatory cytokines (interleukin (IL)-6) and antioxidants (glutathione peroxidase (GPx) and glutathione (GSH)) in type 2 diabetes mellitus (T2DM) patients in Universitas Sumatera Utara (USU) Hospital. METHODS: A total of eighty-nine T2DM patients were recruited at USU Hospital. Glycated Hemoglobin levels were measured using routine laboratory tests at USU Hospital. The IL-6, GPx, and GSH levels were measured using enzyme-linked immunosorbent (ELISA) method. The statistical significance was determined using the Kruskal Wallis test, followed by Mann-Whitney test (p < 0.05). RESULTS: The mean of glycated hemoglobin (%), IL-6 (pg/ml), GPx (ng/ml), and GSH (ng/ml) levels in T2DM patients were 8.96 ± 2.28, 59.27 ± 16.04, 32.13 ± 12.10, and 7.42 ± 3.50, respectively. Regarding the glycated Hemoglobin levels, 28.09% of patients had controlled diabetes, 24.72% of patients had poorly controlled diabetes, and 47.19% of patients had uncontrolled diabetes. The IL-6 levels of the three study groups based on glycated Hemoglobin levels were related significantly (p < 0.05), but there was no statistically significant difference observed between the GPx and GSH levels (p > 0.05). CONCLUSION: The present study suggests that the glycated Hemoglobin was associated with the levels of serum IL-6 levels but not GPx and GSH levels in T2DM patients in USU Hospital.

1 October 2019 in Journal of Physics: Conference Series
Verified
Conference Paper
Open access
PDF file
SSSiti Syarifah
Siti Syarifah
TWTri Widyawati
Tri Widyawati
DADwi Rita Anggraini
Dwi Rita Anggraini
AWArlinda Sari Wahyuni
Arlinda Sari Wahyuni
MSMutiara Indah Sari
Mutiara Indah Sari
Breast cancer was the second most common cancer that causes death in women worldwide. One ingredients of herbal plants as an alternative therapy in the community, was gambir leaves. This research was conducted to examine the anticancer activity of Uncaria gambir Roxb on T47D breast cancer cells in vitro. Six levels of concentration U. gambir (31.25 mg/ml up to 1000 mg/ml) was included on the 96 microplate well which had been filled with breast cancer cells, the positive control was doxorubicin (with concentration of 0.03-1 mg/ml). The anticancer effects of U.gambir was determined by MTT (3-[4,5-dimethylthiazol-2-yl]- diphenyl tetrazolium bromide 2.5). The results showed the existence of anticancer activity of Uncaria gambir Roxb at concentrations of 250, 500 and 1000 μg/ml. The largest anticancer activity found at a concentration of 500 μg/ml with the percentage of apoptotic cells of breast cancer by 20%, but we also found a decrease in the value of the apoptotic at concentration of 1000 μg/ml. The IC50 of U.gambir was 1.086 μg/ml whereas the IC50 doxorubicin was 0.108 μg/ml. This study concluded that the inhibition of breast cancer cell growth by gambir leaves extract was still quite weak compared to doxorubicin.